2021
DOI: 10.1016/j.ymgme.2021.06.011
|View full text |Cite
|
Sign up to set email alerts
|

Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 17 publications
0
8
0
Order By: Relevance
“…The disease is highly heterogeneous and may present from the perinatal period to the seventh decade of life, although most subjects develop symptoms in childhood and die between 10 and 25 years of age [1,[4][5][6]12,13]. The diagnosis of NPC is often delayed in part due to the wide spectrum of clinical phenotypes, which are likely related to underlying genotypes (515 estimated pathogenic mutations) and epigenetic modifiers [5,6,[14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…The disease is highly heterogeneous and may present from the perinatal period to the seventh decade of life, although most subjects develop symptoms in childhood and die between 10 and 25 years of age [1,[4][5][6]12,13]. The diagnosis of NPC is often delayed in part due to the wide spectrum of clinical phenotypes, which are likely related to underlying genotypes (515 estimated pathogenic mutations) and epigenetic modifiers [5,6,[14][15][16].…”
Section: Introductionmentioning
confidence: 99%
“…Albeit the NPC1 and NPC2 complementation groups are indistinguishable biochemically and clinically, it is commonly called NPC1 and NPC2 disease in the literature [58]. However, the high heterogeneity in the clinical manifestations of NPC disease hinders the diagnosis [59]. For these reasons, the diagnosis of NPC disease can take a very long time, even years, and must be assisted by specialists in various disciplines [60][61][62].…”
Section: Niemann Pick Type C Diseasementioning
confidence: 99%
“…NPC1 is a rare disease but the number of patients suffering from NPC may be underestimated or misdiagnosed due to challenges in detecting the disease. 42 Current diagnostic methods such as filipin staining of cholesterol in fibroblasts and mass spectrometry detection of oxysterols are rather unspecific since these lipids may be increased due to other lysosomal storage disorders. 43 Thus, we were curious if our fluorogenic probe 12 identifies cells with a buildup of sphingosine and potentially offer a complementary diagnostic approach.…”
Section: ■ Development Of a Fluorogenic Probe For The Direct Detectio...mentioning
confidence: 99%
“…We next explored if we could detect elevated endogenous sphingosine levels in diseased cell lines. NPC1 is a rare disease but the number of patients suffering from NPC may be underestimated or misdiagnosed due to challenges in detecting the disease . Current diagnostic methods such as filipin staining of cholesterol in fibroblasts and mass spectrometry detection of oxysterols are rather unspecific since these lipids may be increased due to other lysosomal storage disorders .…”
Section: Development Of a Fluorogenic Probe For The Direct Detection ...mentioning
confidence: 99%